AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Forte Biosciences, Inc. Director's Dealing 2017

Dec 14, 2017

33769_dirs_2017-12-14_756c7b24-1c19-447d-8c4e-bf26140da4df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tocagen Inc (TOCA)
CIK: 0001419041
Period of Report: 2017-12-08

Reporting Person: FOLETTA MARK G (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-08	Common Stock	J	2500	$8.50	Acquired	7500	Direct

Footnotes

F1: This Form 4 is being filed voluntarily to report the acquisition of 2,500 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan.